secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2023-04-25T23:59:59+00:00
Accession:  0000950170-23-014246
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma appoints Pamela Garzone to board of directors
-----------------------------------------------------------

- Pamela Garzone appointed to board effective April 19, 2023, following recommendation of committee.
- Received option to purchase 40,000 shares vesting over three years.
- Compensation per Director Compensation Policy; standard indemnification agreement.
- No reportable transactions or arrangements with other persons.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000095017023014246/0000950170-23-014246-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000095017023014246/cue-20230419.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-014246

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer